 CAMBRIDGE, Mass., April 27, 2022 GLOBE NEWSWIRE -- Editas Medicine, Inc. Nasdaq: EDIT, a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, May 4, 2022, at 8:00 a.m. ET to provide a corporate update and results for the first quarter of 2022. 